Blueprint boosts Ayvakit peak sales estimate to $2B fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
E Fund Management Co Ltd Raises Holdings in Blueprint Medicines Co (NASDAQ:BPMC) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
By Emon Reiser Shares of Blueprint Medicines climbed after the company told investors that sales from its drug Ayvakit could grow nearly 80% year over year.
Blueprint Medicines (BPMC) to Release Earnings on Thursday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.